COMPANION-003
Phase 2 Completed
49 enrolled
DOCC
Phase NA Completed
1,550 enrolled
ANGIOPREDICT. ICORG 12-16, V3
Completed
76 enrolled
TraveraRTGx
Completed
72 enrolled
Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study
Phase NA Completed
198 enrolled
Risk Communication Within Mexican-American Families
Completed
498 enrolled
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
Phase NA Completed
24 enrolled
Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy
Completed
100 enrolled
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
Phase NA Completed
188 enrolled
BENEFIT
Completed
341 enrolled
Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
Completed
70 enrolled
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Phase 1/2 Completed
5 enrolled
COLOCROSS
Phase 3 Completed
89 enrolled
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
Completed
175 enrolled
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Phase 2 Completed
24 enrolled 14 charts
00-046
Phase 3 Completed
4,952 enrolled
EHCancer
Phase NA Completed
212 enrolled
Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopic Resection: a Time-to-event Cohort Study
Completed
255 enrolled
FAMCAP
Completed
84 enrolled
The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor Recurrence
Completed
143 enrolled
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Phase NA Completed
150 enrolled
U-Screen
Completed
297 enrolled
Using Visual Arrays to Support Understanding of Genetic Risk
Phase NA Completed
1,045 enrolled
DELARC
Completed
227 enrolled
CIEMAR
Completed
500 enrolled
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Phase 2 Completed
42 enrolled 12 charts
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
Phase NA Completed
16 enrolled
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Phase NA Completed
231 enrolled
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Phase 1 Completed
52 enrolled
Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt
Phase NA Completed
150 enrolled
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits
Completed
1,500 enrolled
PICoC
Phase 3 Completed
40 enrolled 19 charts
T-REX
Completed
3,647 enrolled
TAP
Phase NA Completed
200 enrolled 12 charts
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
Phase 1 Completed
15 enrolled
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
Phase NA Completed
46 enrolled 14 charts
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
PeLear CCC
Phase NA Completed
60 enrolled 13 charts
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
83 enrolled 10 charts